We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Germicidal UV-C System Kills Airborne Pathogens

By HospiMedica International staff writers
Posted on 25 Nov 2020
Rarified-environment technology uses ultraviolet (UV)-C light to kill 99.99% of airborne pathogens, creating ultraclean environments.

The NoviSphere (Elk Grove Village, IL, USA) PE 254 is a cost-effective, high-performance UV pathogen-eradication system that uses fully contained and sealed 254nm UV-C lamps and proprietary baffling technology to kill up to 99.99% of airborne viruses, bacteria, and mold spores. More...
Extensive independent testing has confirmed it also eradicates 99.99% of an aerosol coronavirus strain (HuCov229E), a single-stranded RNA virus that is similar to the COVID-19 strain that causes respiratory illnesses in humans. Further testing is planned to verify 99.9999999% eradication (one part per billion).

The system removes all pathogens in the air, as well as other contaminants, via a variable speed control, that continuously provides up to four complete air changes per hour in a room of an average size. The compact system can be used in virtually any large public setting, including (but not limited to), hospitals, schools, warehouses, manufacturing plants, hospitality, mass transit centers, sports facilities, and a range of industrial and commercial settings.

“At NoviSphere, our mission is to deliver confidence and safety to customers in their communities, workplaces, and businesses. Rarified environments we enable through our technologies are pathogen and particulate free; essentially, a magnitude better than today’s stringent ultraclean standards,” said Paul Lockhart, CEO of NoviSphere. “As a former astronaut entrusted with some of our nation’s most critical assets, I can think of no endeavor more important than what we are embarking on at NoviSphere.”

“Published papers in Aerosol Science & Technology show it is particularly effective against single-stranded RNA viruses,” said Chris Hogan, PhD, of the department of mechanical engineering at the University of Minnesota (Minneapolis, USA), who conducted the testing. “Coronaviruses, and more specifically, SARS-CoV-2, are single-stranded RNA viruses and would be highly susceptible to UV-C activation. Sealed, ducted UV-C sources with flow rates above 10 CFM are an effective approach.”

UVC light in the 254 nm wavelength induces the formation of pyrimidine dimmers from thymine and cytosine; these dimers in turn cause disruptions in microbial DNA, making genetic replication impossible, destroying the organisms or rendering them unable to reproduce. Intense UV-C light also has a proven track record of virus inactivation in aerosols.

Related Links:
NoviSphere


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Glucose Meter
StatStrip®
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.